Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Role of DF3 in human carcinoma and potential therapeutics

May 24, 1996

Medarex presents MDX-210 phase I/II interim results

May 24, 1996

ImClone, E. Merck continue cancer vaccine collaboration

May 24, 1996

Vical, Corixa to collaborate on immunotherapeutic drugs for cancer

May 24, 1996

Patent protection obtained for IDEC-C2B8

May 24, 1996

Genentech completes investment in IDEC ahead of schedule

May 17, 1996

U.S. NDA filed for bropirimine

May 17, 1996

Promising clinical data for GVAX reported at scientific meeting

May 17, 1996

Human Genome Sciences claims chemokine beta-9 polypeptides and their antagonists

May 17, 1996

Melacine NDA filing in sight

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...